Sunny Coast I suspect the partnering up is more PAR (or specifically PR) not wanting to engage until the ducks are in a line. Ie Pricing + IND as this will give them more leverage for a better deal in the % of ongoing that PAR gets.
Once the IND is away and interim 008's I think we will get some traction. Plenty of big Pharma's with lots of Covid $$$ at the moment which may be the opportune time. PR has mentioned that he has Asset valuations of the business so Im sure he is prepared.
Interview 3 with an FDA Process Expert, page-14
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $83.98M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 24.0¢ | $202.2K | 814.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 181098 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 118621 | 5 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |